主动脉瓣置换试验中外科对照的代表性:与常规外科队列的比较
常规实践患者围术期并发症更少,5年生存率更高(低危HR 0.64,中危HR 0.55),提示RCT外科对照组可能不能代表真实世界人群。
要点
- RCT外科组患者围术期卒中、起搏器植入和心肌梗死发生率高于常规实践。
- 常规实践患者5年生存率优于RCT外科组,低危HR 0.64,中危HR 0.55。
- 尽管风险评分相似或更低,RCT外科组长期生存更差,提示外推性受限。
核心结论
- 与常规实践中的典型外科主动脉瓣置换患者相比,RCT外科组患者并发症发生率更高且长期生存更差,尽管手术风险评分相似或更低。
- 这些发现对比较TAVI与SAVR的RCT的外部有效性提出质疑。
研究设计与样本
- 系统文献综述检索PubMed、Embase、Web of Science、Emcare和Cochrane Library,纳入2010年以来低危或中危患者的RCT及大样本前瞻性研究(SAVR患者n≥500)。
- 比较RCT SAVR队列与常规实践队列的患者特征、早期结局和5年生存,行汇总数据Meta分析和重建Kaplan-Meier生存分析,并按风险类别分层。
主要发现
- 常规实践SAVR患者早期死亡率与RCT SAVR患者相当,但围术期并发症更少,包括卒中、起搏器植入和心肌梗死发生率更低。
- 5年总生存率常规实践患者显著高于RCT外科组,低危患者HR 0.64(95%CI 0.55至0.75),中危患者HR 0.55(95%CI 0.47至0.64)。
临床怎么用
- 解读TAVI与SAVR的RCT结果时,需考虑外科对照组可能不能完全代表常规临床实践中的SAVR患者。
- 将RCT结论外推至真实世界SAVR人群时应谨慎,尤其是长期生存和并发症风险方面。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Randomised controlled trials (RCTs) comparing transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR) have significantly influenced treatment guidelines for aortic stenosis, expanding the use of TAVI into lower risk populations. However, the patients enrolled in the SAVR arms of these trials may differ from those typically undergoing SAVR in routine clinical practice. This study aims to critically assess the representativeness of SAVR patients in these RCTs by comparing their characteristics and outcomes to those of patients undergoing SAVR in routine clinical practice. METHODS: A systematic literature review was conducted across PubMed, Embase, Web of Science, Emcare and the Cochrane Library, focusing on RCTs and large prospective studies (n≥500 SAVR patients), enrolling low-risk or intermediate-risk patients since 2010. Patient characteristics, early outcomes and 5-year survival were compared between RCT SAVR cohorts and those treated in routine clinical practice settings. Meta-analyses of pooled data and reconstructed Kaplan-Meier survival analyses were performed, with stratification by risk category. RESULTS: Nineteen studies (9 RCTs and 10 studies describing routine clinical practice), encompassing 74 797 SAVR patients, were included. SAVR patients in routine clinical practice demonstrated comparable early mortality to SAVR patients in RCTs but experienced fewer periprocedural complications, including lower rates of stroke, pacemaker implantation and myocardial infarction. At 5 years, overall survival was notably higher in patients treated in routine clinical practice compared to those in the SAVR arms of RCTs, both for low-risk (HR 0.64, 95% CI 0.55 to 0.75) and intermediate-risk patients (HR 0.55, 95% CI 0.470.64). CONCLUSIONS: Compared with typical SAVR patients treated in routine practice, RCT SAVR patients experienced higher complication rates and worse long-term survival, despite similar or lower surgical risk scores. These findings question the external validity of SAVR versus TAVI trials.
引用
- Tomsic A, Velders BJJ, Kawczynski MJ, et al. Representativeness of surgical controls in aortic valve replacement trials: comparison with routine surgical cohorts. Heart. 2026. PMID: 40633940. doi:10.1136/heartjnl-2025-326162
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。